Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

The trend toward environmental sustainability and a "green" corporate reputation has become a strategic pillar for the world’s leading pharmaceutical companies. With global plastic waste reaching critical levels—where only 20% is recycled or incinerated—top biopharma players like Sanofi, AstraZeneca, Takeda, and GSK are actively implementing measures to reduce their ecological footprint.

Maintaining sustainability within sterile, controlled environments is notoriously difficult. Most cleanroom consumables are non-recyclable due to their chemical composition or hazardous contamination during use. However, innovative materials are now bridging the gap between high-performance contamination control and ecological responsibility.

Introducing ReFIBE™: From Plastic Bottles to Cleanrooms INEX presents the ReFIBE™ woven wipes by CONTEC, a revolutionary product based on the same principle used by sustainable fashion brands: the use of rPET (recycled polyethylene terephthalate).

These wipes are the first of their kind, manufactured from 100% recycled plastic bottles. The environmental impact is substantial:

• 1 Single Pack of wipes prevents 35 plastic bottles from entering landfills or oceans.

• 1 Case of wipes diverts up to 840 plastic bottles from the waste stream.

Performance Without Compromise Despite being recycled, ReFIBE™ wipes are engineered for the most critical environments. They provide a high-performance, single-use solution that ensures neither quality nor production safety is sacrificed.

• Cleanliness Levels: Exceptionally low particle and fiber generation, suitable for ISO Class 3-8 and GMP Grade C/D environments.

• Compatibility: Fully compatible with a wide range of cleanroom cleaning solutions and disinfectants.

• Durability: High sorptive capacity and durability for rigorous surface cleaning.

Using recycled materials in the cleanroom is a small but vital step toward a circular economy in the pharmaceutical industry.